R R

What Is Pioglitazone?

Pioglitazone is a prescription oral medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to the thiazolidinedione class and is available as generic tablets and under the brand name Actos. Pioglitazone helps the body respond more effectively to insulin and is used alongside diet and exercise. It may be prescribed alone or with other diabetes medications. Pioglitazone is not used to treat type 1 diabetes or diabetic ketoacidosis. Its ability to cause fluid retention requires careful assessment of heart failure risk.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Pioglitazone?

Pioglitazone is a prescription oral medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to the thiazolidinedione class and is available as generic tablets and under the brand name Actos. Pioglitazone helps the body respond more effectively to insulin and is used alongside diet and exercise. It may be prescribed alone or with other diabetes medications. Pioglitazone is not used to treat type 1 diabetes or diabetic ketoacidosis. Its ability to cause fluid retention requires careful assessment of heart failure risk.

read more about pioglitazone ...

Copy this HTML:

Copy HTML Copied!

How Does Pioglitazone Work?

Pioglitazone activates peroxisome proliferator-activated receptor gamma, or PPAR-gamma, a nuclear receptor involved in regulating glucose and lipid metabolism. This changes the expression of genes that influence insulin sensitivity in fat, muscle, and liver tissues. By improving the body's response to insulin, pioglitazone helps lower blood glucose levels in people with type 2 diabetes. It does not directly stimulate insulin release from the pancreas. Its effects develop gradually over several weeks, and it requires the presence of insulin to work.

Who Can Receive Pioglitazone Treatment?

Pioglitazone is approved to improve glycemic control in adults with type 2 diabetes when used with diet and exercise. It can be prescribed as monotherapy or combined with other glucose-lowering medications, depending on individual needs. Clinicians consider cardiovascular health, liver function, edema, fracture risk, and other medical conditions before treatment. Pioglitazone should not be initiated in patients with New York Heart Association Class III or IV heart failure. It is not appropriate for type 1 diabetes or diabetic ketoacidosis. Patients with active bladder cancer should generally avoid pioglitazone.

How Should Pioglitazone Be Taken?

Pioglitazone is taken orally once daily, with or without food. Adults without congestive heart failure commonly begin at 15 mg or 30 mg daily, with adjustments based on blood glucose response. The maximum recommended dose is 45 mg once daily. Patients with certain less severe heart failure conditions may require a lower starting dose and close monitoring. Liver tests are obtained before treatment. Clinicians monitor blood sugar levels, weight, swelling, and symptoms of heart failure after treatment begins or the dose increases. Patients should not adjust their dose independently.

What Are the Side Effects and Warnings of Pioglitazone?

Common adverse effects include weight gain, fluid retention, swelling, headache, and upper respiratory symptoms. Pioglitazone carries a boxed warning because it can cause or worsen congestive heart failure. Other serious concerns include bone fractures, liver injury, macular edema, and a possible increased risk of bladder cancer. Low blood sugar is more likely when pioglitazone is combined with insulin or certain other diabetes medications. Rapid weight gain, leg swelling, shortness of breath, blood in the urine, or new blurred vision requires medical evaluation.

Common Questions About Pioglitazone

Is pioglitazone the same as Actos?

Yes. Actos is a brand name for pioglitazone, a thiazolidinedione medication used to improve blood sugar control in adults with type 2 diabetes.

Can pioglitazone cause weight gain?

Yes. Pioglitazone can cause weight gain related to fluid retention and changes in body fat distribution. Rapid weight gain with swelling requires medical assessment.

Can pioglitazone worsen heart failure?

Yes. Pioglitazone carries a boxed warning for causing or worsening congestive heart failure and should not be started in patients with NYHA Class III or IV heart failure.

Can pioglitazone affect eyesight?

Yes. Macular edema has been reported during pioglitazone treatment. New blurred vision or changes in visual acuity should be evaluated by an eye care professional.

References

DailyMed - ACTOS (pioglitazone) tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2ddc491-88a9-4063-9150-443b4fa4330c. Date Accessed October 30, 2026.

Pioglitazone. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548327/. Date Accessed October 30, 2026.

Pioglitazone. MedlinePlus. https://medlineplus.gov/druginfo/meds/a699016.html. Date Accessed October 30, 2026.

Pioglitazone. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Pioglitazone. Date Accessed October 30, 2026.

Pioglitazone. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK544287/. Date Accessed October 30, 2026.